SSU72 Antibody

What is SSU72 and what cellular functions does it perform?

SSU72 is a phosphatase that performs multiple critical cellular functions. In the nucleus, it regulates RNA polymerase II activity, which is essential for transcription processes . Research has also revealed that SSU72 functions as a tyrosine phosphatase for ZAP-70 in T cells, directly binding to ZAP-70 and regulating its tyrosine phosphorylation, thereby providing fine-tuning of T cell receptor (TCR) signaling . Additionally, SSU72 has been identified as a conserved telomere replication terminator that localizes to telomeres in a cell cycle-dependent manner, with peak recruitment occurring during late S phase . These diverse functions make SSU72 an important molecule in cellular regulation across multiple pathways.

In which subcellular compartments is SSU72 typically expressed?

SSU72 demonstrates dynamic subcellular localization that varies by cell type and activation state. Immunohistochemical and immunofluorescence analyses have revealed that SSU72 is expressed in both the nucleus and cytoplasm under basal conditions . Notably, in T cells, SSU72 exhibits low basal expression in naive CD4+ T cells but is strongly upregulated following TCR activation with anti-CD3/28 antibodies . Furthermore, when naive CD4+ T cells are activated with anti-CD3/28 in combination with IL-2 and TGFβ, SSU72 can traffic from the nucleus and cytoplasm to the cytoplasmic face of the plasma membrane . This pattern of expression and translocation indicates that SSU72 has context-dependent functions in different cellular compartments.

What are the validated applications for SSU72 antibody in experimental research?

SSU72 antibody has been validated for multiple experimental applications. Western blot (WB) analysis has been thoroughly validated using various cell lines, including HEK-293T and HeLa cells . Immunohistochemistry (IHC) has been validated on multiple tissue types, including human liver, breast cancer, prostate cancer, and kidney tissues . The antibody is also suitable for ELISA applications . For optimal results in IHC applications, antigen retrieval with TE buffer (pH 9.0) is recommended, although citrate buffer (pH 6.0) can serve as an alternative . These validated applications make SSU72 antibody a versatile tool for investigating the expression and localization of this protein in diverse experimental contexts.

What are the recommended dilutions for different experimental applications?

Based on validation data, the following dilutions are recommended for optimal results with SSU72 antibody:

It's important to note that these are general guidelines, and optimal dilutions may be sample-dependent. Researchers should consider titrating the antibody in their specific testing systems to obtain optimal results . For Western blot applications, a starting dilution of 1:1000 is often appropriate, with adjustments made based on signal intensity and background levels.

How should researchers design experiments to investigate SSU72's role in T cell signaling?

When investigating SSU72's role in T cell signaling, researchers should design experiments that account for its dynamic interaction with ZAP-70. For co-immunoprecipitation experiments, anti-ZAP-70 antibody can be used to pull down the protein complex, followed by Western blotting with anti-SSU72 antibody to detect the interaction . Importantly, the binding between SSU72 and ZAP-70 changes over time following TCR stimulation, with the interaction increasing, peaking, and then decreasing after stimulation with anti-CD3 and anti-CD28 antibodies .

For functional studies, researchers can compare wild-type T cells with Ssu72-deficient T cells, analyzing the phosphorylation status of ZAP-70 (particularly at residues Y292, Y319, and Y493) and downstream molecules like LAT (Y171) and SLP76 (Y145) . Flow cytometric analysis can complement Western blotting by measuring the percentage of p-ZAP-70 (Y319)-positive CD4+ T cells. To establish causality, researchers can use Lck inhibitors at varying concentrations (10-20 nM) to reduce ZAP-70 phosphorylation and determine if this restores normal function in Ssu72-deficient T cells .

What controls should be included when using SSU72 antibody for immunohistochemistry?

When performing immunohistochemistry with SSU72 antibody, several controls should be included to ensure reliable and interpretable results:

• Positive tissue controls: Use tissues known to express SSU72, such as human liver, breast cancer, prostate cancer, or kidney tissues, which have been validated for the antibody .

• Negative controls: Include sections where the primary antibody is omitted but all other steps are performed identically.

• Antibody specificity controls: If possible, include tissues from SSU72-knockout or SSU72-deficient models as a negative control. Research has shown that Ssu72 is not detected in CD4+ T cells from Ssu72-deficient mice, confirming antibody specificity .

• Antigen retrieval optimization: Since antigen retrieval can significantly impact staining results, compare sections processed with the recommended TE buffer (pH 9.0) versus the alternative citrate buffer (pH 6.0) to determine optimal conditions for your specific tissue .

• Dilution series: Test a range of antibody dilutions within the recommended range (1:50-1:500) to determine the optimal concentration that provides specific staining with minimal background .

Why might researchers observe a different molecular weight for SSU72 than predicted?

• Post-translational modifications: Phosphorylation, glycosylation, or other modifications can increase the apparent molecular weight.

• Protein structure: The tertiary structure of the protein may cause it to migrate abnormally during gel electrophoresis.

• Isoforms: Alternative splicing can generate protein variants with different molecular weights.

When troubleshooting unexpected molecular weight observations, researchers should verify antibody specificity using positive and negative controls, consider testing different sample preparation methods that might preserve or eliminate specific modifications, and consult the literature for known isoforms or modifications of SSU72.

How can researchers distinguish between specific and non-specific binding in their SSU72 antibody experiments?

Distinguishing between specific and non-specific binding is critical for accurate data interpretation. Researchers should implement the following strategies:

• Include appropriate controls: Use samples from SSU72-knockout or Ssu72-deficient models where available . For Western blot applications, include lysates from both positive control cells (HEK-293T, HeLa) and cells expected to have low or no expression of SSU72 .

• Perform titration experiments: Test multiple antibody dilutions to identify the concentration that provides the best signal-to-noise ratio.

• Validate with multiple techniques: Confirm findings using complementary approaches. For example, if using immunohistochemistry, validate key findings with Western blot or immunofluorescence.

• Blocking optimization: Adjust blocking conditions to reduce non-specific binding, particularly in immunohistochemistry applications.

• Consider pre-adsorption: In cases of persistent non-specific binding, pre-adsorption of the antibody with the immunizing peptide can help confirm specificity.

How can researchers investigate the cell cycle-dependent recruitment of SSU72 to telomeres?

To study the cell cycle-dependent recruitment of SSU72 to telomeres, researchers can employ the following methodological approach:

• Cell synchronization: Utilize a block-release method, such as the cdc25-22 block-release approach employed in previous studies . Verify synchronization efficiency by measuring the cell septation index.

• Chromatin immunoprecipitation (ChIP): Perform ChIP with anti-SSU72 antibody at different time points throughout the cell cycle. For telomere detection, design primers specific to telomeric regions or use techniques specifically developed for repetitive sequences.

• Co-localization studies: Combine immunofluorescence for SSU72 with fluorescence in situ hybridization (FISH) using telomere-specific probes to visualize recruitment in intact cells.

• Temporal correlation: Compare the timing of SSU72 recruitment with known markers of telomere replication, such as the arrival of lagging-strand machinery at chromosome ends .

• Genetic manipulations: Generate and analyze SSU72 deletion mutants (ssu72Δ) and phosphatase-inactive point mutants (e.g., ssu72-C13S) to investigate the functional consequences of SSU72 absence or inactivity on telomere length and replication .

What approaches can be used to study the interaction between SSU72 and ZAP-70 in T cell signaling?

The interaction between SSU72 and ZAP-70 in T cell signaling can be investigated using multiple complementary approaches:

• Affinity purification-mass spectrometry: This approach has successfully identified the specific interaction between SSU72 and ZAP-70 in T cells .

• Co-immunoprecipitation assays: Immunoprecipitate with anti-ZAP-70 antibody and blot for SSU72, or vice versa. This approach has demonstrated that binding increases, peaks, and then decreases after TCR stimulation .

• Domain mapping: Generate constructs with mutations or deletions in specific domains to identify interaction sites. Previous research has shown that N-terminal amino acids (1-80) of SSU72 and amino acids (1-131) of ZAP-70, containing the N-SH2 domain, are critically involved in the interaction .

• Functional assays: Compare phosphorylation of ZAP-70 and downstream molecules in wild-type versus SSU72-deficient T cells to assess functional consequences of the interaction .

• In vitro phosphatase assays: Use recombinant SSU72 and phosphorylated ZAP-70 to directly assess the phosphatase activity of SSU72 on ZAP-70 .

• Pharmacological interventions: Use Lck inhibitors at specific concentrations (10-20 nM) to modulate ZAP-70 phosphorylation and determine if this restores normal function in SSU72-deficient T cells .

What storage and handling precautions should researchers take with SSU72 antibody?

To maintain optimal antibody performance, researchers should adhere to these storage and handling guidelines:

How can researchers optimize SSU72 antibody usage for studying T cell differentiation and activation?

When studying T cell differentiation and activation using SSU72 antibody, consider these optimization strategies:

• Timing considerations: Since SSU72 expression and localization change in response to TCR stimulation, carefully time sample collection for different activation states. SSU72 is strongly activated by anti-CD3/28 and shows recruitment to the plasma membrane when activated with anti-CD3/28 in combination with IL-2 and TGFβ .

• Cell isolation and purity: For ex vivo studies, ensure high purity of isolated T cell populations using appropriate isolation techniques such as magnetic bead separation or fluorescence-activated cell sorting.

• Activation protocols: When studying SSU72 in T cell activation, standardize activation protocols. Previous studies have used anti-CD3 and anti-CD28 monoclonal antibodies to stimulate T cells and analyze SSU72's role in signaling .

• Differential expression analysis: Consider comparing SSU72 expression across different T cell subsets (naive, effector, memory, regulatory) as studies have shown that SSU72 influences the differentiation of naive T cells into effector and memory T cells .

• Phenotypic markers: Include analysis of activation markers (CD44, CD62L) alongside SSU72 staining, as SSU72-deficient mice show altered proportions of naive (CD44loCD62Lhi) versus effector-memory (CD44hiCD62Llo) T cells .